FDA Lightens Up on Nictotine Replacement Products

FDA Lightens Up on Nictotine Replacement Products

April 1st, 2013 // 4:03 pm @

The Food and Drug Administration is relaxing its restrictions on the use of over-the-counter nicotine patches, gum and lozenges.

Currently, consumers are instructed to stop smoking when they begin using a nicotine replacement product and to stop using it after 12 weeks.

April 3 – Audit Your Lab Like an Expert FDA Auditor: A Roadmap to Lab Compliance

The FDA plans to remove both these restrictions in response to claims by critics that they may cause some smokers to abandon attempts to quit if they have a cigarette while on a replacement therapy.

Allowing people to stay on a nicotine replacement for longer than 12 weeks may increase their chance of quitting, they say.

The FDA said nicotine patches and gum were first approved between 1984 and 1992, while nicotine lozenges and mini-lozenges were approved in 2002-2009.

After reviewing published literature, the agency said it has determined that the concomitant use of cigarettes and other nicotine-containing products “does not raise significant safety concerns.”

Upcoming Expertbriefings.com Webinars 2013

Check out our exclusive FDA drug and device news, too

Subscribe Now

Featured Partner